MedTrace Logo

Mobile Medical Application for Cost-effective Strabismus Screening

NCT03450980 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 91

Last updated 2025-07-14

Study results available
· View outcomes & findings →

Summary

Develop and evaluate a new smartphone based app to screen for and measure eye misalignment (strabismus). The investigators will validate the app against simulated strabismus of known magnitude and common clinical tests. They will evaluate the app as a screening tool in high risk populations, to determine the sensitivity and specificity. They hypothesize that the app can measure to within 2 units (prism diopters) of the ground truth, and that it will be correlated with gold standard tests.

Conditions

  • Strabismus

Sponsors & Collaborators

  • National Eye Institute (NEI)

    collaborator NIH

  • Massachusetts Eye and Ear Infirmary

    lead OTHER

Principal Investigators

  • Gang Luo, PhD · Massachusetts Eye and Ear

Eligibility

Min Age
18 Years
Max Age
88 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-02-01
Primary Completion
2019-12-30
Completion
2025-01-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03450980 on ClinicalTrials.gov